ArisGlobal Closes 2021 with Tremendous Growth Across Customer Base, Talent, and Revenue, Further Solidifying Its Leadership in Life Sciences R&D Software
Life sciences technology pioneer delivers record bookings and double-digit increase ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
Life sciences technology pioneer delivers record bookings and double-digit increase ...
Premier pharmaceutical company adopts LifeSphere Multivigilanceto centralize pharmacovigilance activities MIAMI ...
ArisGlobal’s industry leading pharmacovigilance platform automates the intake, triage, and ...
Report reveals how life sciences companies currently use automation and ...
Innovative R&D company selects LifeSphere by ArisGlobal to further develop ...
ArisGlobal's LifeSphere clinical and regulatory product leader will host a ...
The life sciences R&D technology leader will lead keynote sessions ...
Miami, Florida, Tokyo, August 23, 2021 Asahi Kasei Pharma Corp. ...
ArisGlobal LifeSphere IDMP Requirements, Readiness and Capabilities Acknowledged in Gens ...
ArisGlobal recognized by Frost & Sullivan for enabling life sciences ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved